Of the 369 patients, 205 (55.6%) were included in the low-risk group, 150 (40.7%) in the moderate-risk group, and 14 (3.8%) in the high-risk group. A total of 174 (47.2%) patients were smokers, 79 (21.4%) were obese, and 93 (25.2%) had hyperlipidemia. The study included 285 male patients (77.2%) and 84 (22.8%) female patients. The frequency of complications of anterior wall myocardial infarction at the time of discharge was compared among these groups. Patients were divided into three groups: low-risk, moderate-risk, and high-risk TIMI groups. The TIMI score was calculated by proforma at the time of admission. A total of 369 patients were selected who had anterior wall myocardial infarction and received thrombolytic therapy, according to the inclusion and exclusion criteria. The study duration was six months, from Septemto March 23, 2017. This study was designed to determine the frequency of cardiac complications of anterior wall STEMI assessed on TIMI risk score and to compare the rate of cardiac complications according to the TIMI score.Īn observational case series study was conducted in the Department of Cardiology at Sandeman Provincial Hospital in Quetta, Pakistan. The Thrombolysis in Myocardial Infarction (TIMI) risk score for ST-segment elevation myocardial infarction (STEMI) is based on eight high-risk parameters that can be used at the bedside for risk stratification of patients presenting with STEMI. 2000 284 (7): 835-42.Effective risk stratification is integral to the management of acute coronary syndromes. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an emergency department. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Morrow DA, Antman EM, Charlesworth A et-al. female first-degree relative or mother younger than 65 yearsĪ percentage risk at 14 days of all-cause mortality, new or recurrent myocardial infarction, or severe recurrent ischemia requiring urgent revascularization.male first-degree relative or father younger than 55 years.family history of premature coronary artery disease.hypertension >140/90 mmHg or on anti-hypertensives.at least 3 risk factors for coronary artery disease, which include:. known coronary artery disease (CAD) (coronary stenosis ≥50%).ST changes of at least 0.5 mm in contiguous leads.at least 2 angina episodes in the last 24 hours.aspirin use within the last 7 days (patient has chest pain despite as required use in past 7 days).It is thought to have potential to improve the management of patients presenting to hospital with undifferentiated chest pain where ischemic heart disease is a potential diagnosis 3. The thrombolysis in myocardial infarction (TIMI) risk score is a prognostic risk stratification system that categorizes the risk of death and ischemic events in patients with unstable angina / non-ST elevation myocardial infarction and provides a basis for therapeutic decision making.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |